Liquidia (LQDA) Depreciation & Amortization (CF) (2020 - 2026)
Liquidia (LQDA) recorded quarterly Depreciation & Amortization (CF) of $497000.0 in Q1 2026, up 55.31% quarter-over-quarter from $320000.0 in Q4 2025, and up 10.2% on a YoY basis from $451000.0 in Q1 2025.
Liquidia (LQDA) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Liquidia's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $497000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 10.2% year-over-year to $497000.0; the TTM figure through Mar 2026 stood at $1.6 million (down 27.1% YoY), while the FY2025 annual figure was $1.5 million, down 30.45% from the prior year.
- Depreciation & Amortization (CF) was $497000.0 for Q1 2026 at Liquidia, up from $320000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.1 million in Q3 2022 to a low of $281000.0 in Q2 2025.
- Historically, Depreciation & Amortization (CF) has averaged $591000.0 across 5 years, with a median of $518000.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) tumbled 54.43% in 2023, then gained 18.68% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $566000.0 in 2022, then fell by 10.6% to $506000.0 in 2023, then grew by 2.37% to $518000.0 in 2024, then tumbled by 38.22% to $320000.0 in 2025, then jumped by 55.31% to $497000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $497000.0 (Q1 2026), $320000.0 (Q4 2025), and $476000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 7.20 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 22.68 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 497,000.00 |
| 10 | Hims & Hers Health | 6.15 Bn | 5.40 Bn | 396.79 Mn | 21.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 497,000.00 |
| Mar 31, 2026 | 497,000.00 |
| Dec 31, 2025 | 320,000.00 |
| Dec 31, 2025 | 320,000.00 |
| Sep 30, 2025 | 476,000.00 |
| Sep 30, 2025 | 476,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 451,000.00 |
| Mar 31, 2025 | 451,000.00 |
| Dec 31, 2024 | 518,000.00 |
| Dec 31, 2024 | 518,000.00 |
| Sep 30, 2024 | 610,000.00 |
| Sep 30, 2024 | 610,000.00 |
| Jun 30, 2024 | 580,000.00 |
| Jun 30, 2024 | 580,000.00 |
| Mar 31, 2024 | 489,000.00 |
| Mar 31, 2024 | 489,000.00 |
| Dec 31, 2023 | 506,000.00 |
| Dec 31, 2023 | 506,000.00 |